The Effects of Acarbose on the Postprandial Hypotensive Response in Older Adults

Q: What is the clinical evidence from this study?

Study design: RCT. Population: Postprandial hypotension (n=43). Intervention: Acarbose vs. Placebo. Primary outcome: Average decrease in systolic blood pressure (PPHmean) (standardized β 0.724, p=0.017).

Q: What does this research mean for the field?

Acarbose attenuates the mean decrease in systolic blood pressure during a meal test but results in significantly more postprandial hypotensive events compared to placebo in older adults. Novelty: ClaimNovelty.CONTRADICTORY. Consensus alignment: ConsensusAlignment.CHALLENGES_CONSENSUS.

Kenneth Madden; Boris Feldman; Graydon S. Meneilly

doi:10.1017/s0714980825100056

July 28, 2025Canadian Journal on Aging / La Revue canadienne du vieillissementOpen Access

The Effects of Acarbose on the Postprandial Hypotensive Response in Older Adults

View Full Paper

Ask AI

Bookmark

Share

Key result

Acarbose blunts meal-induced SBP drops vs placebo but increases postprandial hypotensive events in older adults.

standardized β 0.724
P=0.017
n=43

Why the study?

Acarbose has been recommended for postprandial hypotension based exclusively on studies in older adults with diabetes, leaving its effects in a broader older adult population unclear.

Does acarbose improve the postprandial hypotensive response in older adults?

Study Design

Type

RCT (n=43)

Blinding

Triple-blind

Randomization

Off-site randomization

Multicenter

No

Structured PICO

Does acarbose improve the postprandial hypotensive response in older adults?

P

Population

43 older adults (≥65 years old, mean age 77.1, 53% female) recruited from geriatric medicine outpatient clinics in Canada. Excluded: history of stroke, coronary artery disease, uncontrolled hypertension, smoking in the last 5 years, chronic respiratory disease, orthostatic hypotension, or current use of alpha-glucosidase inhibitors.

I

Intervention

Acarbose 50 mg oral given immediately prior to the administration of a standardized meal

C

Comparator

Matching placebo given immediately prior to the administration of a standardized meal

O

Outcome

Average decrease in systolic blood pressure (PPHmean) and average maximal change in systolic blood pressure (PPHmax) during a 90-minute meal testsurrogate

Main Result

Effect estimate: standardized β 0.724

Absolute Event Rate: 2.3% vs -13.8%

p-value: p=0.017

Acarbose attenuated the mean decrease in systolic blood pressure during a meal test in older adults but paradoxically increased the number of postprandial hypotensive events, suggesting it may not be an effective treatment for postprandial hypotension in the general older adult population.

Limitations

Subject pool was heterogeneous and modest in size
Subjects were only studied once rather than in a longitudinal design
The test meal did not have a high caloric content
Results occurred in an artificial laboratory setting, limiting clinical extrapolation
Heterogeneous and modest sample size
Test meal did not have a high caloric content
Results occurred in an artificial laboratory setting

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Acarbose may increase postprandial hypotensive events despite mean SBP attenuation; does not support use and leaves optimal management open.

Abstract

Postprandial hypotension (PPH) is defined as a postprandial decline in systolic blood pressure (SBP) of 20 mm of Hg. Some have recommended the use of acarbose (an alpha-glucosidase inhibitor) as a potential therapy for PPH based exclusively on studies of older adults with diabetes. Using a randomized placebo-controlled design, 43 older adults (23 women, 20 men, mean age 77.1 ± 0.9 years) were recruited from geriatric medicine outpatient clinics in an academic centre. Although the average decrease in SBP during the meal test was significantly attenuated in the acarbose group (standardized β = 0.724 ± 0.286, p = 0.017), the acarbose group experienced significantly more PPH events (standardized β = 0.593 ± 0.279, p = 0.040). Although acarbose attenuated the mean decrease in SBP during the meal test, it did not reduce the actual number of PPH events recorded in a general population of older adults. ClinicalTrials.gov ID NCT01914133.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Madden et al. (2025) conducted an RCT in Postprandial hypotension (n=43). Acarbose vs. Placebo was evaluated on Average decrease in systolic blood pressure (PPHmean) (standardized β 0.724, p=0.017). Acarbose attenuated the mean decrease in systolic blood pressure during a meal test but resulted in significantly more postprandial hypotensive events compared to placebo in older adults.

synapsesocial.com/papers/6a12c18213ab6312a8c07a47 https://doi.org/10.1017/s0714980825100056

View Full Paper

Ask AI

Bookmark

Share

The Effects of Acarbose on the Postprandial Hypotensive Response in Older Adults

Study Design

Structured PICO

Main Result

Limitations

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

The Effects of Acarbose on the Postprandial Hypotensive Response in Older Adults

Study Design

Structured PICO

Main Result

Limitations

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading